P. Argani, M. Y. Lui, J. Couturier, R. Bouvier, J. C. Fournet et al., A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23), Oncogene, vol.22, pp.5374-5378, 2003.

T. Bawa-khalfe and E. T. Yeh, SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression, Genes & cancer, vol.1, pp.748-752, 2010.

C. Beisland, O. Talleraas, A. Bakke, and J. Norstein, Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study, BJU international, vol.97, pp.698-702, 2006.

C. Bertolotto, P. Abbe, T. J. Hemesath, K. Bille, D. E. Fisher et al., Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes, J Cell Biol, vol.142, pp.827-835, 1998.
URL : https://hal.archives-ouvertes.fr/inserm-02532974

C. Bertolotto, K. Bille, J. P. Ortonne, and R. Ballotti, Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product, J Cell Biol, vol.134, pp.747-755, 1996.
URL : https://hal.archives-ouvertes.fr/inserm-02533106

C. Bertolotto, R. Busca, P. Abbe, K. Bille, E. Aberdam et al., Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia, Mol Cell Biol, vol.18, pp.694-702, 1998.
URL : https://hal.archives-ouvertes.fr/inserm-02533084

C. Bertolotto, F. Lesueur, S. Giuliano, T. Strub, M. De-lichy et al., A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, pp.94-98, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01791271

L. Beuret, M. Ohanna, T. Strub, M. Allegra, I. Davidson et al., BRCA1 is a new MITF target gene, Pigment Cell Melanoma Res, vol.24, pp.725-727, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530733

P. T. Bradford, D. M. Freedman, A. M. Goldstein, and M. A. Tucker, Increased risk of second primary cancers after a diagnosis of melanoma, Arch Dermatol, vol.146, pp.265-272, 2010.

B. Bressac-de-paillerets, M. F. Avril, A. Chompret, and F. Demenais, Genetic and environmental factors in cutaneous malignant melanoma, Biochimie, vol.84, pp.67-74, 2002.

R. Busca, E. Berra, C. Gaggioli, M. Khaled, K. Bille et al., Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells, J Cell Biol, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00321685

S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo et al., Mitf regulation of Dia1 controls melanoma proliferation and invasiveness, Genes Dev, vol.20, pp.3426-3439, 2006.

Y. Cheli, M. Ohanna, R. Ballotti, and C. Bertolotto, Fifteen-year quest for microphthalmia-associated transcription factor target genes, Pigment Cell Melanoma Res, vol.23, pp.27-40, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-02530740

M. Collado, M. A. Blasco, and M. Serrano, Cellular senescence in cancer and aging, Cell, vol.130, pp.223-233, 2007.

J. C. Cronin, J. Wunderlich, S. K. Loftus, T. D. Prickett, X. Wei et al., Frequent mutations in the MITF pathway in melanoma, Pigment Cell Melanoma Res, vol.22, pp.435-444, 2009.

H. Davies, G. R. Bignell, C. Cox, P. Stephens, S. Edkins et al., Mutations of the BRAF gene in human cancer, Nature, vol.417, pp.949-954, 2002.

I. J. Davis and D. E. Fisher, MiT transcription factor associated malignancies in man, Cell Cycle, vol.6, pp.1724-1729, 2007.

I. J. Davis, B. L. Hsi, J. D. Arroyo, S. O. Vargas, Y. A. Yeh et al., Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation, Proc Natl Acad Sci U S A, vol.100, pp.6051-6056, 2003.

I. J. Davis, J. J. Kim, F. Ozsolak, H. R. Widlund, O. Rozenblatt-rosen et al., Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers, Cancer Cell, vol.9, pp.473-484, 2006.

M. C. Fargnoli, S. Gandini, K. Peris, P. Maisonneuve, and S. Raimondi, MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis, Eur J Cancer, vol.46, pp.1413-1420, 2010.

L. A. Garraway, H. R. Widlund, M. A. Rubin, G. Getz, A. J. Berger et al., Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, vol.436, pp.117-122, 2005.

P. Ghiorzo, L. Pastorino, P. Queirolo, W. Bruno, M. G. Tibiletti et al., Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history, Pigment Cell Melanoma Res, vol.26, pp.259-262, 2013.

G. Giaever, A. M. Chu, L. Ni, C. Connelly, L. Riles et al., Functional profiling of the Saccharomyces cerevisiae genome, Nature, vol.418, pp.387-391, 2002.

S. Giuliano, Y. Cheli, M. Ohanna, C. Bonet, L. Beuret et al., Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas, Cancer Res, vol.70, pp.3813-3822, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-02530789

S. Giuliano, M. Ohanna, R. Ballotti, and C. Bertolotto, Advances in melanoma senescence and potential clinical application. Pigment Cell Melanoma Res In press, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530650

D. Hanahan and R. A. Weinberg, Hallmarks of cancer: the next generation, Cell, vol.144, pp.646-674, 2011.

L. Hou, J. J. Panthier, and H. Arnheiter, Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF, Development, vol.127, pp.5379-5389, 2000.

C. J. Hussussian, J. P. Struewing, A. M. Goldstein, P. A. Higgins, D. S. Ally et al., Germline p16 mutations in familial melanoma, Nat Genet, vol.8, pp.15-21, 1994.

E. Y. Kim, L. Chen, Y. Ma, W. Yu, J. Chang et al., Expression of sumoylation deficient Nkx2.5 mutant in Nkx2.5 haploinsufficient mice leads to congenital heart defects, J Invest Dermatol, vol.6, pp.1763-1774, 2011.

W. M. Linehan, G. Bratslavsky, P. A. Pinto, L. S. Schmidt, L. Neckers et al., Molecular diagnosis and therapy of kidney cancer, Annual review of medicine, vol.61, pp.329-343, 2010.

E. Maubec, V. Chaudru, H. Mohamdi, F. Grange, J. J. Patard et al., Characteristics of the coexistence of melanoma and renal cell carcinoma, Cancer, vol.116, pp.5716-5724, 2010.

A. J. Miller, C. Levy, I. J. Davis, E. Razin, and D. E. Fisher, Sumoylation of MITF and its related family members TFE3 and TFEB, J Biol Chem, vol.280, pp.146-155, 2005.

Y. Y. Mo, Y. Yu, E. Theodosiou, P. L. Ee, and W. T. Beck, A role for Ubc9 in tumorigenesis, Oncogene, vol.24, pp.2677-2683, 2005.

J. R. Morris, C. Boutell, M. Keppler, R. Densham, D. Weekes et al., The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress, Nature, vol.462, pp.886-890, 2009.

H. Murakami and H. Arnheiter, Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner, Pigment Cell Res, vol.18, pp.265-277, 2005.

K. Nacerddine, F. Lehembre, M. Bhaumik, J. Artus, M. Cohen-tannoudji et al., The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice, Dev Cell, vol.9, pp.769-779, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-02075525

E. K. Nishimura, S. R. Granter, and D. E. Fisher, Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche, Science, 2004.

V. Pingault, D. Ente, . Dastot-le, F. Moal, M. Goossens et al., Review and update of mutations causing Waardenburg syndrome, Hum Mutat, vol.31, pp.391-406, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00483195

K. D. Sarge and O. K. Park-sarge, SUMO and its role in human diseases, International review of cell and molecular biology, vol.288, pp.167-183, 2011.

M. H. Schmid-wendtner, J. Baumert, C. M. Wendtner, G. Plewig, and M. Volkenandt, Risk of second primary malignancies in patients with cutaneous melanoma, Br J Dermatol, vol.145, pp.981-985, 2001.

M. S. Soengas and S. W. Lowe, Apoptosis and melanoma chemoresistance, Oncogene, vol.22, pp.3138-3151, 2003.

E. Steingrimsson, N. G. Copeland, and N. A. Jenkins, Melanocytes and the microphthalmia transcription factor network, Annu Rev Genet, vol.38, pp.365-411, 2004.

E. Steingrimsson, L. Tessarollo, B. Pathak, L. Hou, H. Arnheiter et al., Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development, In Proc Natl Acad Sci, pp.4477-4482, 2002.

T. Strub, S. Giuliano, T. Ye, C. Bonet, C. Keime et al., Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma, Oncogene, vol.30, pp.2319-2332, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530755

R. A. Sturm, C. Fox, P. Mcclenahan, K. Jagirdar, M. Ibarrola-villava et al., Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients, J Invest Dermatol, 2013.

M. Tsuda, I. J. Davis, P. Argani, N. Shukla, G. G. Mcgill et al., TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition, Cancer Res, vol.67, pp.919-929, 2007.

X. D. Wang, E. Lapi, A. Sullivan, I. Ratnayaka, R. Goldin et al., SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence, Cell Death Differ, vol.18, pp.304-314, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00570132

M. J. Weterman, J. J. Van-groningen, A. Jansen, and A. G. Van-kessel, Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins, Oncogene, vol.19, pp.69-74, 2000.

K. A. Wilkinson and J. M. Henley, Mechanisms, regulation and consequences of protein SUMOylation, Biochem J, vol.428, pp.133-145, 2010.

Y. H. Wu, G. H. Kim, J. D. Wagner, A. F. Hood, and T. Y. Chuang, The association between malignant melanoma and noncutaneous malignancies, International journal of dermatology, vol.45, pp.529-534, 2006.

S. Yokoyama, S. L. Woods, G. M. Boyle, L. G. Aoude, S. Macgregor et al., A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, pp.99-103, 2011.

Y. Q. Zhang, S. , and K. D. , Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies, J Cell Biol, vol.182, pp.35-39, 2008.

L. Zuo, J. Weger, Q. Yang, A. M. Goldstein, M. A. Tucker et al., Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma, Nat Genet, vol.12, pp.97-99, 1996.